Thymocartin

Thymocartin

SCHEMBL29355849

CC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
NPY1R P25929 1/20 0.50
NPY2R P49146 1/20 0.50
NPY4R P50391 1/20 0.50
FURIN P09958 10/20 0.49
PCSK6 P29122 1/20 0.49
CTSL P07711 1/20 0.49
ERAP2 Q6P179 2/20 0.47
LNPEP Q9UIQ6 2/20 0.47
PRSS1 P07477 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29351042 0.93 ERAP2 (0.52) NPY1RNPY2RNPY4RFURINERAP2
SCHEMBL1738257 0.88 NPY1R (0.53) NPY1RNPY2RNPY4RFURINERAP2
Thymotrinan SCHEMBL15532089 0.88 NPY1R (0.53) NPY1RNPY2RNPY4RFURINERAP2
Thymotrinan SCHEMBL1738371 0.88 NPY1R (0.53) NPY1RNPY2RNPY4RFURINERAP2
SCHEMBL29776755 0.88 GSR (0.44) ERAP2
SCHEMBL11102541 0.85 FURIN (0.42) FURIN
Thymopentin SCHEMBL1651175 0.85 NPY1R (0.70) NPY1RNPY2RNPY4R
Thymopentin SCHEMBL44002 0.85 NPY1R (0.70) NPY1RNPY2RNPY4R
SCHEMBL11249367 0.84 FOLH1 (0.52)
SCHEMBL29518434 0.84 LNPEP (0.60) NPY1RNPY2RNPY4RFURINERAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116574155-A Tetrapeptide compound TP-4, preparation method and application 兰州大学 2023-08-11 CN claimed
CN-115431601-B Porous structure fills type intermediate layer composite sheet 燕山大学 2023-08-04 CN claimed
CN-115431601-A Porous structure fills type intermediate layer composite sheet 燕山大学 2022-12-06 CN claimed
EP-3544761-B1 IRRADIATING DEVICE AND MACHINE TOOL COMPRISING SAME TRUMPF LASER & SYSTEMTECHNIK GMBH (DE) 2022-08-31 EP claimed
CN-114177314-A Application of thymopentin and derivatives thereof in preparation of tumor diagnosis and/or treatment reagent 江西中医药大学 2022-03-15 CN claimed
CN-116850307-B Application of polypeptide TP-6 in preparation of tumor diagnosis and/or treatment reagent JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE (CN) 2026-05-26 CN disclosed
CN-122071534-A Fusion protein, conjugate containing same, kit and application 菲鹏生物股份有限公司 2026-05-22 CN disclosed
US-12571907-B2 Inverse synthetic aperture, multiband radar detection of hidden objects with spatially structured tracking of object carrier THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2026-03-10 US disclosed
US-12552803-B2 Organic electroluminescent element, material for organic electroluminescent element, light emitting device, display device and lighting device each using said element, and compound used for said element UDC IRELAND LIMITED (IE) 2026-02-17 US disclosed
EP-3964494-B1 METHOD FOR SYNTHESIZING CHIRAL 2-HYDROXY-1,4-DICARBONYL COMPOUND AND PANTOLACTONE UNIV LANZHOU (CN) 2026-01-14 EP disclosed
US-20250388753-A1 POLYMER COMPOSITIONS COMPRISING ALKYL SILICONE AND ARTICLES FORMED FROM SAME CORNING INC (US) 2025-12-25 US disclosed
US-12452968-B2 Operation of a domestic microwave appliance as a function of a microwave generator temperature BSH Hausgeräte GmbH (DE) 2025-10-21 US disclosed
CN-114177314-A Application of thymopentin and derivatives thereof in preparation of tumor diagnosis and/or treatment reagent 江西中医药大学 2022-03-15 CN disclosed
CN-114163539-A TP recombinant antigen and preparation method and application thereof 青岛硕景生物科技有限公司 2022-03-11 CN disclosed
US-20220077413-A1 Organoelectroluminescent Element, and Light Emission Device, Display Device, and Illumination Device in which Said Organoelectroluminescent Element is Used UDC IRELAND LTD (IE) 2022-03-10 US disclosed
EP-3964494-A1 METHOD FOR SYNTHESIZING CHIRAL 2-HYDROXY-1,4-DICARBONYL COMPOUND AND PANTOLACTONE Lanzhou University (CN) 2022-03-09 EP disclosed
CN-114128402-A Operating a microwave household appliance as a function of the temperature of a microwave generator BSH家用电器有限公司 2022-03-01 CN disclosed
US-11238534-B2 Method and system for commingling aggregate prices and franchise prices JPMORGAN CHASE BANK, N.A. (US) 2022-02-01 US disclosed
US-20220025170-A1 METHOD FOR PRODUCING THERMOPLASTIC RESIN COMPOSITION AND THERMOPLASTIC RESIN COMPOSITION INOAC CORPORATION (JP) 2022-01-27 US disclosed
US-11230568-B2 Melanocortin 1 receptor ligands and methods of use H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2022-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11230568-B2 Melanocortin 1 receptor ligands and methods of use MC1R, MC3R, MC5R NPY1R 14/4885NPY2R 45/4885NPY4R 40/4885
US-20250388753-A1 POLYMER COMPOSITIONS COMPRISING ALKYL SILICONE AND ARTICLES FORMED FROM SAME LSM8, SMCHD1, CASP8 NPY1R 3746/4885NPY2R 3161/4885NPY4R 3618/4885
US-12571907-B2 Inverse synthetic aperture, multiband radar detection of hidden objects with spatially structured tracking of object carrier RXFP3, RXFP4, TSHR NPY1R 12/4885NPY2R 18/4885NPY4R 30/4885
US-12552803-B2 Organic electroluminescent element, material for organic electroluminescent element, light emitting device, display device and lighting device each using said element, and compound used for said element H1-0, H1-2, H1-5 NPY1R 482/4885NPY2R 530/4885NPY4R 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.